Correlation of serum arylesterase activity on phenylacetate estimated by the integrated method to common classical biochemical indexes of liver damage.
- Author:
Fei LIAO
1
;
Xiao-yun ZHU
;
Yong-mei WANG
;
Yun-sheng ZHAO
;
Lian-ping ZHU
;
Yu-ping ZUO
Author Information
1. Laboratory of Bioinformatics & Molecular Engineering, Chongqing Key Laboratory of Biochemistry & Molecular Pharmacology, College of Pharmaceutical Sciences, Chongqing Medical University, Chongqing 400016, China. liaofeish@yahoo.com
- Publication Type:Journal Article
- MeSH:
Alanine Transaminase;
blood;
Aryldialkylphosphatase;
blood;
Aspartate Aminotransferases;
blood;
Biomarkers;
Carboxylic Ester Hydrolases;
blood;
Clinical Laboratory Techniques;
Humans;
Liver Diseases;
blood;
enzymology;
Liver Function Tests;
Phenylacetates
- From:
Journal of Zhejiang University. Science. B
2007;8(4):237-241
- CountryChina
- Language:English
-
Abstract:
The correlation of serum arylesterase (PON1) activity on phenylacetate determined by an integrated method to classical biochemical indexes of liver damage was investigated for the use of PON1 activity to evaluate liver damage. PON1 reaction curve as absorbance at 270 nm for 0.20 mmol/L phenylacetate hydrolysis was analyzed by the integrated method to determine maximal PON1 reaction rate. Classical biochemical indexes of liver damage were determined routinely. The 95% confidence threshold of PON1 activity in sera from healthy individuals was 2.12 mkat/L [(4.73+/-1.31) mkat/L, n=105]. PON1 activity in clinical sera was closely correlated to serum albumin, total protein and the ratio of albumin to globulins, but was weakly correlated to both direct and total bilirubin in serum. There were no correlations of PON1 activity to gamma-glutamyltransferase, alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase. Among 127 clinical sera with PON1 activity>2.12 mkat/L, there were 92% healthy individuals examined by albumin, 90% healthy individuals examined by total protein, 88% healthy individuals examined by total bilirubin, 86% healthy individuals examined by direct bilirubin and 64% healthy individuals examined by the ratio of albumin to globulins, respectively. In each group of healthy individuals judged by classical biochemical indexes of close correlation to PON1 activity, percentage of healthy individuals examined by PON1 activity was always >80%. These results suggested PON1 activity on phenylacetate estimated by the integrated method was also suitable for the evaluation of liver damage.
